Related Experiment Video
Updated: Jul 15, 2026

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay
Published on: January 26, 2019
Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques
Daria J Hazuda1, Steven D Young, James P Guare
1Department of Biological Chemistry, Merck Research Laboratories, Post Office Box 4, West Point, PA 19486, USA. daria_hazuda@merck.com
Abstract:
We describe the efficacy of L-870812, an inhibitor of HIV-1 and SIV integrase, in rhesus macaques infected with the simian-human immunodeficiency virus (SHIV) 89.6P. When initiated before CD4 cell depletion, L-870812 therapy mediated a sustained suppression of viremia, preserving CD4 levels and permitting the induction of virus-specific cellular immunity. L-870812 was also active in chronic infection; however, the magnitude and durability of the effect varied in conjunction with the pretreatment immune response and viral load. These studies demonstrate integrase inhibitor activity in vivo and suggest that cellular immunity facilitates chemotherapeutic efficacy in retroviral infections.
Related Concept Videos
Retrovirus Life Cycles
Viruses with RNA Genomes
Respiratory Syncytial Virus Disease
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly

